Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9K Buy
187
+10
+6% +$1.21K ﹤0.01% 2022
2026
Q1
$28.9K Sell
177
-22
-11% -$3.38K ﹤0.01% 1555
2025
Q4
$34.6K Sell
199
-17
-8% -$3.1K ﹤0.01% 1516
2025
Q3
$31.1K Buy
216
+7
+3% +$858 ﹤0.01% 1377
2025
Q2
$21K Buy
209
+36
+21% +$2.75K ﹤0.01% 1476
2025
Q1
$13.2K Buy
173
+17
+11% +$1.3K ﹤0.01% 1641
2024
Q4
$10.8K Buy
+156
New +$11.2K ﹤0.01% 1733

Other funds holding INSM

BFC Planning, Inc.'s INSM Position: Q2 2026 in Review

BFC Planning, Inc. increased its Insmed (INSM) stake by 5.6% in Q2 2026, buying an estimated $1.21K and bringing the position to 187 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

BFC Planning, Inc. first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $34.6K in Q4 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • BFC Planning, Inc. held 187 shares of Insmed worth $19.9K as of Q2 2026.
  • BFC Planning, Inc. bought 10 Insmed shares in Q2 2026, an estimated $1.21K.
  • Insmed made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2022 holding.
  • BFC Planning, Inc. first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Insmed position peaked at $34.6K in Q4 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.